Difference between revisions of "Network Pathways Chart"
From GcatWiki
Ktrueblood1 (talk | contribs) |
Ktrueblood1 (talk | contribs) |
||
| Line 9: | Line 9: | ||
| [[Media:Ellen_Johnson_proposal.docx]] || Sucrose degradation || align="center" |? || Natural|| Anabolic || Selection || Cells that can degrade sucrose survive | | [[Media:Ellen_Johnson_proposal.docx]] || Sucrose degradation || align="center" |? || Natural|| Anabolic || Selection || Cells that can degrade sucrose survive | ||
|- | |- | ||
| − | | [[Media:Duke_DeLoache_Proposal.docx]]|| Biosynthetic pathway of L-tryptophan into violacein || align="center" |5 || Natural|| Anabolic || Screening || E. coli | + | | [[Media:Duke_DeLoache_Proposal.docx]]|| Biosynthetic pathway of L-tryptophan into violacein || align="center" |5 || Natural|| Anabolic || Screening || Violacein producing E. coli have increased anti-tumor, antiviral, and antifungal resistance |
|} | |} | ||
Latest revision as of 21:07, 25 May 2012
| Student Proposal | Network Pathway | Number of Steps | Natural vs. Synthetic | Catabolic vs. Anabolic | Screening vs. Selection | Relationship to Cell Fitness |
|---|---|---|---|---|---|---|
| Media:Ellen_Johnson_proposal.docx | Vanillin Synthesis | 11+ | Synthetic | Catabolic | Selection | Tetracycline resistant cells live |
| Media:Ellen_Johnson_proposal.docx | Tetracycline biosynthesis pathway | 27 | Synthetic | Catabolic | Selection | Vanillin producing cells survive |
| Media:Ellen_Johnson_proposal.docx | Sucrose degradation | ? | Natural | Anabolic | Selection | Cells that can degrade sucrose survive |
| Media:Duke_DeLoache_Proposal.docx | Biosynthetic pathway of L-tryptophan into violacein | 5 | Natural | Anabolic | Screening | Violacein producing E. coli have increased anti-tumor, antiviral, and antifungal resistance |
